{"transactions":[{"id":738805,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2026-06-15T23:00:03.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":132066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":132066,"derivative":{"exercise_price":4.65,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":132066},"source":{"system":"sec-edgar","filing":"0001493152-26-028766","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315226028766/ownership.xml","form_type":"4"}},{"id":1144247,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2025-05-19T20:31:12.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":1.48,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001641172-25-011475","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000164117225011475/ownership.xml","form_type":"4"}},{"id":1237464,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-03T21:05:12.000Z","date":"2024-08-13","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":1.13,"value":6780.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the addition of 664 shares that were inadvertently omitted from the Reporting Person's original Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.12 to $1.13. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the addition of 664 shares that were inadvertently omitted from the Reporting Person's original Form 4."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001493152-25-008863","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315225008863/ownership.xml","form_type":"4/A","original_submission_date":"2024-08-13"}},{"id":1301134,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2025-01-17T21:07:03.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty-six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":1.42,"expiration_date":"2035-01-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-25-002764","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315225002764/ownership.xml","form_type":"4"}},{"id":1435435,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-13T22:56:00.000Z","date":"2024-08-13","kind":"purchase","planned":false,"acquired":true,"shares":5336,"price":1.13,"value":6029.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.12 to $1.13. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":7836,"source":{"system":"sec-edgar","filing":"0001493152-24-031725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315224031725/ownership.xml","form_type":"4"}},{"id":1681220,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2024-01-11T21:05:38.000Z","date":"2024-01-10","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably in two equal installments on December 4, 2025 and December 4, 2026."}],"balance_after":0,"derivative":{"exercise_price":2.42,"exercise_date":"2026-12-04","expiration_date":"2034-01-10","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-24-002057","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315224002057/ownership.xml","form_type":"4"}},{"id":1711766,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-14T14:00:19.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.19,"value":5475.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.14 to $2.22. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001493152-23-044805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315223044805/ownership.xml","form_type":"4"}},{"id":2060308,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-06T21:59:18.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":161200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 161,200 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027."}],"balance_after":161200,"derivative":{"exercise_price":11.61,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":161200},"source":{"system":"sec-edgar","filing":"0001140361-23-000826","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123000826/form4.xml","form_type":"4"}},{"id":2473539,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-14T14:10:53.000Z","date":"2021-12-13","kind":"purchase","acquired":true,"shares":100,"price":9,"value":900.0,"ownership":{"direct":false,"nature":"Daughter"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired on the open market."}],"balance_after":4075,"source":{"system":"sec-edgar","filing":"0001140361-21-041473","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121041473/form4.xml","form_type":"4"}},{"id":2473538,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-14T14:10:53.000Z","date":"2021-12-13","kind":"purchase","acquired":true,"shares":100,"price":9,"value":900.0,"ownership":{"direct":false,"nature":"Son"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired on the open market."}],"balance_after":3975,"source":{"system":"sec-edgar","filing":"0001140361-21-041473","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121041473/form4.xml","form_type":"4"}},{"id":2473537,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-14T14:10:53.000Z","date":"2021-12-13","kind":"purchase","acquired":true,"shares":400,"price":8.9,"value":3560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired on the open market."}],"balance_after":3875,"source":{"system":"sec-edgar","filing":"0001140361-21-041473","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121041473/form4.xml","form_type":"4"}},{"id":2473536,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-14T14:10:53.000Z","date":"2021-12-13","kind":"purchase","acquired":true,"shares":2500,"price":9,"value":22500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired on the open market."}],"balance_after":3475,"source":{"system":"sec-edgar","filing":"0001140361-21-041473","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121041473/form4.xml","form_type":"4"}},{"id":2538135,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-20T20:31:00.000Z","date":"2021-10-19","kind":"grant","acquired":true,"shares":202800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended.  The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on October 19, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":202800,"derivative":{"exercise_price":12.03,"expiration_date":"2031-10-19","underlying":"Common Stock","underlying_shares":202800},"source":{"system":"sec-edgar","filing":"0001140361-21-034999","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121034999/form4.xml","form_type":"4"}},{"id":2981735,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"SSKN Stock Options (right to buy)","published_at":"2020-11-13T16:40:57.000Z","date":"2020-11-13","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest in 3 equal annual installments commencing on November 13, 2021 and continuing through November 13, 2023."}],"balance_after":150000,"derivative":{"exercise_price":1.46,"expiration_date":"2030-11-13","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001051514-20-000062","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000105151420000062/form4.xml","form_type":"4"}},{"id":3359144,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"SSKN Stock Options (right to buy)","published_at":"2019-11-26T16:49:44.000Z","date":"2019-11-22","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest in 3 equal annual installments commencing on November 22, 2020 and continuing through November 22, 2022."}],"balance_after":400000,"derivative":{"exercise_price":2.46,"expiration_date":"2029-11-22","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001051514-19-000132","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000105151419000132/form4.xml","form_type":"4"}},{"id":3894344,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"SSKN Common Stock","published_at":"2018-06-14T15:32:03.000Z","date":"2018-06-14","kind":"purchase","acquired":true,"shares":1812,"price":1.95,"value":3533.4,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001140361-18-028569","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000114036118028569/doc1.xml","form_type":"4"}},{"id":3894343,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"SSKN Common Stock","published_at":"2018-06-14T15:32:03.000Z","date":"2018-06-14","kind":"purchase","acquired":true,"shares":4542,"price":1.96,"value":8902.32,"ownership":{"direct":true},"balance_after":8188,"source":{"system":"sec-edgar","filing":"0001140361-18-028569","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000114036118028569/doc1.xml","form_type":"4"}},{"id":3894342,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"SSKN Common Stock","published_at":"2018-06-14T15:32:03.000Z","date":"2018-06-14","kind":"purchase","acquired":true,"shares":3646,"price":1.97,"value":7182.62,"ownership":{"direct":true},"balance_after":3646,"source":{"system":"sec-edgar","filing":"0001140361-18-028569","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000114036118028569/doc1.xml","form_type":"4"}},{"id":3919021,"issuer":{"id":72980,"kind":"organization","name":"STRATA Skin Sciences, Inc.","symbol":"SSKN"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"STRATA Stock Option (right to buy)","published_at":"2018-05-24T16:07:14.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest in three equal installments over a three year period on each of the following dates: on May 23 2019; May 23, 2020 and on May 23, 2021."}],"balance_after":250000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-05-23","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001140361-18-025504","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051514/000114036118025504/doc1.xml","form_type":"4"}}]}